QBFM
VNDA icon

QS Batterymarch Financial Management’s Vanda Pharmaceuticals VNDA Stock Holding History

QS Batterymarch Financial Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.26M Sell
121,103
-97,467
-45% -$1.28M 0.03% 490
2014
Q2 		$3.54M Sell
218,570
-21,800
-9% -$290K 0.09% 347
2014
Q1 		$3.91M Hold
240,370
– – 0.08% 356
2013
Q4 		$2.98M Sell
240,370
-2,000
-0.8% -$20.1K 0.06% 408
2013
Q3 		$2.65M Buy
+242,370
New +$2.59M 0.06% 438

Other funds holding VNDA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
SCA
Signpost Capital Advisors New York $34.2M AUM 5.08% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

QS Batterymarch Financial Management's VNDA Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its Vanda Pharmaceuticals (VNDA) stake by 45% in Q3 2014, selling an estimated $1.28M and leaving 121,103 shares worth $1.26M. The position accounts for 0.03% of the portfolio, ranked #490.

QS Batterymarch Financial Management first reported a position in VNDA in Q3 2013 and has held it in 5 quarters since. The position peaked at $3.91M in Q1 2014. 101 funds tracked by Wall St. Rank hold VNDA as of Q3 2014.

  • QS Batterymarch Financial Management held 121,103 shares of Vanda Pharmaceuticals worth $1.26M as of Q3 2014.
  • QS Batterymarch Financial Management sold 97,467 Vanda Pharmaceuticals shares in Q3 2014, an estimated $1.28M.
  • Vanda Pharmaceuticals made up 0.03% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #490 holding.
  • QS Batterymarch Financial Management first reported a position in Vanda Pharmaceuticals in Q3 2013 and has held it in 5 quarters since.
  • QS Batterymarch Financial Management's Vanda Pharmaceuticals position peaked at $3.91M in Q1 2014.
  • 101 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.